| Invasive fusariosis in the voriconazole era: single-center 13-year experience JM Stempel, SP Hammond, DA Sutton, LM Weiser, FM Marty Open Forum Infectious Diseases 2 (3), ofv099, 2015 | 67 | 2015 |
| Comparison of extracorporeal photopheresis and alemtuzumab for the treatment of chronic lung allograft dysfunction A Moniodis, K Townsend, A Rabin, O Aloum, J Stempel, P Burkett, ... The Journal of Heart and Lung Transplantation 37 (3), 340-348, 2018 | 33 | 2018 |
| Bicarbonate use and mortality outcome among critically ill patients with metabolic acidosis: a meta analysis KB Lo, V Garvia, JM Stempel, P Ram, J Rangaswami Heart & Lung 49 (2), 167-174, 2020 | 18 | 2020 |
| Trends and outcomes of venous thromboembolism in hospitalized patients with ovarian cancer: results from nationwide inpatient sample database 2003 to 2011 V Mittal, S Ahuja, SS Vejella, JM Stempel, V Palabindala, CM Dourado, ... International Journal of Gynecologic Cancer 28 (8), 2018 | 11 | 2018 |
| Erdheim-Chester disease, moving away from the orphan diseases: a case report JM Stempel, JGB Alvarez, AM Carpio, V Mittal, C Dourado Respiratory medicine case reports 20, 55-58, 2017 | 11 | 2017 |
| False positive fourth generation HIV test in a patient with severe malaria JM Stempel, ALM Carpio, D Puga, S Perloff International Journal of Infectious Diseases 83, 86-87, 2019 | 8 | 2019 |
| Second malignancies among older patients with classical myeloproliferative neoplasms treated with hydroxyurea R Wang, RM Shallis, JM Stempel, SF Huntington, AM Zeidan, SD Gore, ... Blood Advances 7 (5), 734-743, 2023 | 7 | 2023 |
| Transthyretin cardiac amyloidosis and aortic stenosis: connection and therapeutic implications J Penalver, M Ambrosino, HD Jeon, A Agrawal, N Kanjanahattakij, ... Current Cardiology Reviews 16 (3), 221-230, 2020 | 7 | 2020 |
| Time-to-reporting of blood culture positivity and central venous catheter-associated Candida glabrata fungemia in cancer patients JM Stempel, D Farmakiotis, JJ Tarrand, DP Kontoyiannis Diagnostic Microbiology and Infectious Disease 85 (3), 391-393, 2016 | 6 | 2016 |
| Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia NA Podoltsev, R Wang, RM Shallis, JM Stempel, M Di, N Neparidze, ... Cancer Medicine 12 (18), 18889-18900, 2023 | 5 | 2023 |
| Supportive Care for Patients With Myelodysplastic Syndromes JM Stempel, NA Podoltsev, T Dosani The Cancer Journal 29 (3), 168-178, 2023 | 3 | 2023 |
| Cost-effectiveness of azacitidine and ivosidenib in newly diagnosed older, intensive chemotherapy-ineligible patients with IDH1-mutant acute myeloid leukemia JP Bewersdorf, KK Patel, G Goshua, RM Shallis, NA Podoltsev, M Stahl, ... Leukemia & Lymphoma 64 (2), 454-461, 2023 | 3 | 2023 |
| Examination of speakership gender disparity at an international oncology conference. J Caro, C Boatwright, X Li, C Fiocco, JM Stempel, JH Stoeckle, JW Smithy, ... Journal of Clinical Oncology 40 (16_suppl), 11002-11002, 2022 | 3 | 2022 |
| Pulmonary arterial hypertension in hospitalized patients with polycythemia vera (from the National Inpatient Database) JM Stempel, A Gopalakrishnan, P Krishnamoorthy, KB Lo, V Mittal, ... American Journal of Cardiology 143, 154-157, 2021 | 3 | 2021 |
| Pneumococcal bacteremia and meningitis AL Mora Carpio, JM Stempel New England Journal of Medicine 379 (21), 2063-2063, 2018 | 3 | 2018 |
| Older patients with chronic myeloid leukemia face suboptimal molecular testing and tyrosine kinase inhibitor adherence RM Shallis, R Wang, AM Zeidan, SF Huntington, N Neparidze, ... Blood Advances 7 (13), 3213-3224, 2023 | 2 | 2023 |
| Birth characteristics and risk of meningioma in a population-based study in California DJ Cote, R Wang, LM Morimoto, C Metayer, J Stempel, G Zada, X Ma, ... Neuro-oncology advances 4 (1), vdac173, 2022 | 2 | 2022 |
| Invaginación intestinal en el adulto secundaria a sarcoma yeyunal. Resolución mediante abordaje laparoscópico: reporte de un caso y revisión de la literatura V Baez, O Rodríguez, R Sánchez, J Stempel, JG Rosciano, LG Medina Vitae, 2015 | 2 | 2015 |
| Evolution of Therapeutic Benefit Measurement Criteria in Myelodysplastic Syndromes/Neoplasms JM Stempel, Z Xie, JP Bewersdorf, M Stahl, AM Zeidan The Cancer Journal 29 (3), 203-211, 2023 | 1 | 2023 |
| Second Malignancies Among Older Patients with Classical Myeloproliferative Neoplasms Treated with Ruxolitinib JM Stempel, R Wang, RM Shallis, SF Huntington, AM Zeidan, ... Blood 140 (Supplement 1), 11004-11006, 2022 | 1 | 2022 |
